Press-release for stocks

Prices are updated after-hours

crawled date : 2021 - 08 - 11 source : Www.biospace.com

save search

Xeris Pharmaceuticals Announces FDA Acceptance of its IND Application for XeriSol™ Levothyroxine (XP-8121) for the Treatment of Hypothyroidism
Published: 2021-08-11 (Crawled : 22:00) - biospace.com/
XERS | $1.77 -0.56% -0.56% 1.1M

Health Technology

| -22.94% | O: 0.43% H: 1.29% C: 1.29%
treatment fda fda acceptance application

VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update
Published: 2021-08-11 (Crawled : 22:00) - biospace.com/
VNRX | $0.6172 3.89% 1.26% 260K

Health Technology

| -81.03% | O: 0.64% H: 11.18% C: 2.24%
financial results results

NRx Pharmaceuticals to Report Second Quarter 2021 Results August 16, 2021
Published: 2021-08-11 (Crawled : 22:00) - biospace.com/
NRXP | $3.025 -27.63% -38.18% 760K

Manufacturing

| -76.6% | O: -3.92% H: 1.4% C: -6.76%
results

Navidea Biopharmaceuticals Reports Second Quarter 2021 Financial Results
Published: 2021-08-11 (Crawled : 22:00) - biospace.com/
NAVB | $0.042 50.69% 12K

Health Technology

| -97.59% | O: 1.81% H: 2.37% C: 0.59%
biopharma financial results results

Accuray Reports Fourth Quarter and Fiscal 2021 Financial Results
Published: 2021-08-11 (Crawled : 22:00) - biospace.com/
ARAY | $2.21 0.91% 0.9% 690K

Health Technology

| -44.42% | O: -0.5% H: 0.0% C: -1.0%
financial results results

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2021 Financial Results
Published: 2021-08-11 (Crawled : 21:00) - biospace.com/
DMAC | $2.45 -5.77% -6.12% 17K

Health Technology

| -27.42% | O: 1.47% H: 0.29% C: -2.31%
CRNX | $43.005 -2.28% -2.34% 540K

Health Technology

| 147.1% | O: 10.0% H: 6.56% C: -1.24%
financial results results

Spruce Biosciences to Host Virtual R&D Day on August 25, 2021
Published: 2021-08-11 (Crawled : 21:00) - biospace.com/
SPRB | $0.7064 0.03% 0.03% 290K

Health Technology

| -91.02% | O: 2.02% H: 0.0% C: -1.12%
bioscience

I-Mab’s Antibody for Severe COVID-19 Looks Good in Interim Analysis
Published: 2021-08-11 (Crawled : 18:00) - biospace.com/
IMAB | $1.795 -0.83% -0.84% 140K

Health Technology

| -97.69% | O: -6.04% H: 0.27% C: -2.71%
covid antibody covid-19

Emergent’s Woes Are Dire but Not Insurmountable, Legal Expert Says
Published: 2021-08-11 (Crawled : 18:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -16.69% | O: 0.28% H: 0.13% C: -0.26%
merge

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 for COVID-19First-in-human study evaluating recombinant hyperimmunes
Published: 2021-08-11 (Crawled : 15:00) - biospace.com/
GRFS | News | $6.53 -0.76% -0.77% 760K

Health Technology

| -55.21% | O: -0.14% H: 1.09% C: -0.55%
covid phase 1 antibody trial

Annovis Bio Completes Dosing of Parkinson's Disease Patients with ANVS401 in Phase 2a Clinical Trial
Published: 2021-08-11 (Crawled : 14:15) - biospace.com/
ANVS | $9.85 9.57% 0.96% 240K

Health Technology

| -75.14% | O: 1.13% H: 0.0% C: -9.15%
disease phase 2 parkinson trial phase 2b anvs401

Ethicon's Echelon Circular Powered Stapler Associated With Major Reduction In Serious Complications Following Colorectal Surgery
Published: 2021-08-11 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -16.69% | O: 0.28% H: 0.13% C: -0.26%

IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial with Allogeneic Gamma Delta T-Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant
Published: 2021-08-11 (Crawled : 14:00) - biospace.com/
INAB | $1.04 4.0% 3.85% 130K

| -89.79% | O: 5.4% H: 0.0% C: -4.45%
stem cell phase 1 therapy leukemia trial t-cell

Money on the Move: August 4 – 10
Published: 2021-08-11 (Crawled : 14:00) - biospace.com/
ABCL | $3.92 0.0% 770K

| -74.02% | O: 0.26% H: 0.67% C: -2.24%

AbbVie's Soliton Acquisition Hits a Snag as FTC Increases Scrutiny
Published: 2021-08-11 (Crawled : 14:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| 42.77% | O: 0.3% H: 0.16% C: -1.25%
acquisition

Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021
Published: 2021-08-11 (Crawled : 14:00) - biospace.com/
VYNT | $0.194 -8.51% 19K

Health Care and Social Assistan...

| -93.45% | O: 0.0% H: 2.18% C: -0.73%
conference

AcQMap 8, Acutus Medical’s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE MarkEnhanced Software Automatically Identifies Regions of Interest During the Treatment of Complex Atrial Arrhythmias
Published: 2021-08-11 (Crawled : 13:15) - biospace.com/
AFIB | $0.1744 6.47% 6.08% 730K

Health Technology

| -98.86% | O: 0.63% H: 1.04% C: -0.41%
fda clearance treatment fda software ce mark trial clearance

Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Published: 2021-08-11 (Crawled : 13:15) - biospace.com/
SRNE | $0.028 -8.85% 42K

Health Technology

| -99.66% | O: 0.0% H: 1.36% C: 0.68%
DYAI A | $1.605 -4.46% -4.67% 37K

Health Technology

| -49.86% | O: 20.33% H: 28.7% C: 22.22%
covid vaccine license technology

Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression
Published: 2021-08-11 (Crawled : 13:15) - biospace.com/
BMRA | $0.751 0.0% 55K

Health Technology

| -81.4% | O: 2.02% H: 0.0% C: -0.74%
depression patent

GentiBio Nets $157 Million to Restore Immune Tolerance with Tregs
Published: 2021-08-11 (Crawled : 13:15) - biospace.com/
IBIO | $1.77 -6.35% -0.57% 180K

Health Technology

| 45.38% | O: 0.0% H: 0.77% C: -3.85%